Submit to JPM Review for JPM Edit a Special Issue

Journal Menu

Journal Browser

Special Issue "Towards Personalized Interventions for Health and Wellbeing"

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: closed (5 April 2023) | Viewed by 3923

Share This Special Issue

Special Issue Editor

Dr. Afsane Riazi

E-Mail Website
Guest Editor

Department of Psychology, Richmond the American International University in London, Richmond TW10 6JP, UK
Interests: wellbeing; quality of life; interventions; patient-reported outcomes; health psychology; psychometrics; qualitative research

Special Issue Information

Dear Colleagues,

As the scientific advances in genomics promise treatments that are tailored to the genetic characteristics of the individual, increasing attention is being paid to personalising interventions for health and wellbeing. There is intuitive appeal in assuming that targeting interventions to groups or individuals who are most likely to be responsive to an intervention, or specifically adapting and tailoring an intervention for an individual, would bring significant benefits in health when compared to an approach where such individual differences and characteristics are not considered. The science of personalised interventions, especially in the context of mental health and wellbeing, will also need to consider factors beyond the individual’s underlying genetic and biological mechanisms. This Special Issue of the Journal of Personalized Medicine aims to highlight the current state of research and showcase some of the latest findings in this field. It is hoped that scientific advances in the evidence-based methods for tailoring interventions to individuals will ultimately pave the way towards incorporating personalised interventions for health and wellbeing in clinical practice that is rooted in science.

Dr. Afsane Riazi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

personalised interventions
wellbeing
interventions
tailoring treatments
psychological interventions
individual differences
interventions
mental health
health
tailored interventions

Published Papers (4 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Open AccessArticle

The Lübeck Medication Satisfaction Questionnaire—A Novel Measurement Tool for Therapy Satisfaction

and

J. Pers. Med. 2023, 13(3), 505; https://doi.org/10.3390/jpm13030505 - 10 Mar 2023

Viewed by 680

Abstract

Background: Therapy satisfaction is widely considered an important aspect of clinical care. Still, there are currently no freely available questionnaires for its measurement. We developed the Lübeck Medication Satisfaction Questionnaire (LMSQ) for that purpose. Here, we present its content and psychometric properties. Methods: The LMSQ was validated on 86 patients in a single center study. The Kaiser-Meyer-Olkin test, confirmatory factor analysis, covariance analysis, and a test of exact fit were performed. Reliability was tested using Cronbach’s α and McDonald’s ω. The relationship to other patient-reported outcomes was tested using Pearson’s correlation. Results: Confirmatory factors analysis yielded moderate factor loadings with p < 0.001 in all subscales. Reliability was adequate (α = 0.857 and ω = 0.872). Model fitness was excellent in all tests. The LMSQ was positively correlated with medication adherence (r = 0.603, p < 0.001) and most dimensions of health literacy. Conclusions: The LMSQ possesses adequate psychometric properties for its purpose. We recommend further validation in a more diverse patient collective. Full article

(This article belongs to the Special Issue Towards Personalized Interventions for Health and Wellbeing)

► Show Figures

Figure 1

Open AccessArticle

MRI and Ultrasound Analysis of Corticosteroid Injection Combined with Extracorporeal Shockwave Therapy in Lateral Epicondylitis—A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial

Gopal Nambi

Mshari Alghadier

Elturabi Elsayed Ebrahim

Anju Verma

Osama R. Aldhafian

Shahul Hameed Pakkir Mohamed

Shady Abdullah Alshewaier

Mohamed Sherif Sirajudeen

Hariraja Muthusamy

and

Radhakrishnan Unnikrishnan

J. Pers. Med. 2022, 12(11), 1892; https://doi.org/10.3390/jpm12111892 - 11 Nov 2022

Viewed by 736

Abstract

Objective: The knowledge about the effective implementation of corticosteroid injection and extracorporeal shockwave therapy on radiological changes in chronic lateral epicondylitis is lacking. Therefore, the objective of this study is to find and compare the effects of corticosteroid injection and extracorporeal shockwave therapy on radiological changes in chronic lateral epicondylitis. Methods: A randomized, double-blinded controlled study was conducted on 60 LE participants at a university hospital. The active extracorporeal shockwave therapy group (n = 30) received a corticosteroid injection with active extracorporeal shockwave therapy one session a week for 4 weeks, and the placebo extracorporeal shockwave therapy group received a corticosteroid injection with placebo extracorporeal shockwave therapy. The primary outcome was pain intensity, measured with the visual analog scale. The other outcome measures were the percentage of injury measured by magnetic resonance imaging and ultrasound, functional disability, handgrip strength, patient perception, kinesiophobia, depression status, and quality of life. Results: The between-group difference in pain intensity at 4 weeks was 1.4 (CI 95% 0.77 to 2.02), which shows more improvement in the active group than in the placebo group. Improvements in the effects were noted after 8 weeks and at 6 months (1.8; CI 95% 1.50 to 2.09) follow-up. Similar improvements were also found in the percentage of injury, functional disability, handgrip strength, patient perception, kinesiophobia, depression status, and quality of life. Conclusion: Extracorporeal shockwave therapy has added effects on corticosteroid injection for improving pain, percentage of injury, functional disability, handgrip strength, patient perception, kinesiophobia, depression status and quality of life in people with chronic lateral epicondylitis. Full article

(This article belongs to the Special Issue Towards Personalized Interventions for Health and Wellbeing)

► Show Figures

Figure 1

Open AccessArticle

Experiences of Barriers to Self-Compassion in Women Experiencing Weight Difficulties: An Interpretative Phenomenological Analysis

Anna Jeziorek

and

Afsane Riazi

J. Pers. Med. 2022, 12(9), 1504; https://doi.org/10.3390/jpm12091504 - 14 Sep 2022

Viewed by 848

Abstract

There is currently little understanding of why some individuals find it difficult to engage in self-compassion (SC), defined as a form of self-kindness, self-acceptance, and courage to face one’s distress. This is especially true for women experiencing weight difficulties, despite the emergence of promising results from compassion-focused approaches to weight management. Consequently, this study undertakes a qualitative study to explore the experiences of barriers to self-compassion in women who were actively trying to manage their weight, using interpretative phenomenological analysis (IPA). A qualitative study was employed using an interpretive approach. Using purposive sampling, 10 women were recruited from London-based weight loss groups. Three super-ordinate themes emerged: (I) feeling unable to prioritise own needs over others’ needs; (II) having to learn and sustain a new approach to weight loss; and (III) having very high standards. The emergent themes suggest that women who face weight difficulties have numerous barriers to self-compassion. To fully utilise compassionate-based weight loss interventions for women, it is important to recognise these barriers and implement strategies to lessen their impact. Full article

(This article belongs to the Special Issue Towards Personalized Interventions for Health and Wellbeing)

Open AccessArticle

Problem-Solving Treatment for People Recently Diagnosed with Visual Impairment: Pilot Randomised Controlled Trial

Laurence Mynors-Wallice

Miriam O’Driscoll

and

Kate Walters

J. Pers. Med. 2022, 12(9), 1431; https://doi.org/10.3390/jpm12091431 - 31 Aug 2022

Viewed by 754

Abstract

Background: Problem-Solving Treatment (PST) has been used to treat and prevent depression in a variety of settings. However, the impact of PST on improving psychological well-being in those with recent vision loss remains unknown. The aim of this study was to evaluate whether PST may lead to better psychological well-being in people with recent vision loss through a pilot parallel-group randomised controlled trial. Methods: Participants who were diagnosed with visual impairment during the previous 3 months were randomly allocated to either an 8-week PST or treatment as usual (N = 61). Outcome measures were administered at baseline, 3, 6, and 9-months. Results: A linear mixed model demonstrated that PST significantly improved psychological well-being (measured by the Warwick Edinburgh Mental Well-being Scale) (treatment effect = 2.44; 95% CI = 0.40–4.47; p = 0.019). Significant improvements in the PST group for symptoms of distress, quality of life and self-efficacy were also observed. There was no significant difference in mobility. The treatment effect was consistent at all follow-ups. Attrition rate was low (13%). Conclusions: PST was associated with a significant and sustained improvement in a range of outcomes in people with recent vision loss. Further large scale RCT is now required. Full article

(This article belongs to the Special Issue Towards Personalized Interventions for Health and Wellbeing)

► Show Figures

Journal Menu

Journal Browser

Special Issue "Towards Personalized Interventions for Health and Wellbeing"

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Published Papers (4 papers)

Research

Further Information

Guidelines

MDPI Initiatives

Follow MDPI